Zobrazeno 1 - 10
of 645
pro vyhledávání: '"J M, Azorin"'
Publikováno v:
IEEE Access, Vol 9, Pp 49121-49130 (2021)
Motor imagery (MI) is one of the most common paradigms used in brain-computer interfaces (BCIs). This mental process is defined as the imagination of movement without any motion. In some lower-limb exoskeletons controlled by BCIs, users have to perfo
Externí odkaz:
https://doaj.org/article/bec708642ad94180896c439f67471c71
Publikováno v:
IEEE Access, Vol 9, Pp 134259-134269 (2021)
Footwear comfort is one of the determinant factors in a buyout decision. The understanding of which brain patterns are involved in the comfort perception of footwear could be an important element to develop the consumer neuroscience field, and could
Externí odkaz:
https://doaj.org/article/4322f0fa02bd4e9793e3b24e7ece9a69
Autor:
Nicolas Simon, J M Azorin
Publikováno v:
L'Encéphale. 44:558-564
Aripiprazole may be viewed as the prototype of third-generation antipsychotics. This concept is based on the notion of D2 partial agonism, whereas all molecules of first-and second generation were D2 antagonists. After reviewing the basic pharmacolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29006b2a6dcb0819f3768b54346dcc73
https://doi.org/10.1016/j.encep.2018.10.003
https://doi.org/10.1016/j.encep.2018.10.003
Autor:
Giulio Perugi, G. Maccariello, Cecilia Mainardi, J.-M. Azorin, Jules Angst, Allan H. Young, Sergey Mosolov, C.L. Bowden, Eduard Vieta, Margherita Barbuti, Isabella Pacchiarotti, Norma Verdolini
Publikováno v:
European Neuropsychopharmacology. 29:S353-S355
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b92c0e35b197126a7d4c8f43805b9fe0
https://doi.org/10.1016/j.euroneuro.2018.11.547
https://doi.org/10.1016/j.euroneuro.2018.11.547
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J.-M. Azorin, Raoul Belzeaux, Michel Cermolacce, Marc Adida, Clélia Quiles, E. Fakra, Jean-Arthur Micoulaud-Franchi
Publikováno v:
L'Encéphale. 42:S51-S59
RESUME Objectifs Cet article se donne pour objectifs, premierement de rappeler l’histoire de l’electroconvulsivotherapie (ECT) en psychiatrie et le passage dans ce contexte d’un niveau de preuve clinique fonde sur les descriptions phenomenologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea815e01b02a73a6f85f8bdee9d403b7
https://doi.org/10.1016/s0013-7006(17)30055-6
https://doi.org/10.1016/s0013-7006(17)30055-6
Autor:
Amélie Marsot, David Braunstein, E. Fakra, Xavier Zendjidjian, Viktor K. Jirsa, Romain Guilhaumou, Farid Kheloufi, C Riff, Sylvie Bonin-Guillaume, Olivier Blin, Marc Adida, Maxime Guye, Joëlle Micallef, Quentin Boucherie, Julien Dupouey, Raoul Belzeaux, J.-M. Azorin
Publikováno v:
L'Encéphale
L'Encéphale, 2016, 42 (6), pp.S2-S6. ⟨10.1016/S0013-7006(17)30046-5⟩
L'Encéphale, 2016, 42 (6), pp.S2-S6. ⟨10.1016/S0013-7006(17)30046-5⟩
Clinical trials in psychiatry allow to build the regulatory dossiers for market authorization but also to document the mechanism of action of new drugs, to build pharmacodynamics models, evaluate the treatment effects, propose prognosis, efficacy or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d1c67bf509a2c7e6d2a7c06eb4570a
https://doi.org/10.1016/s0013-7006(17)30046-5
https://doi.org/10.1016/s0013-7006(17)30046-5
Autor:
Marc Adida, E. Fakra, J.-M. Azorin, J.-A. Micoulaud Franchi, Raoul Belzeaux, Michel Cermolacce
Publikováno v:
L'Encéphale. 42:S18-S25
RESUME L’effet placebo represente un enjeu central dans le champ des essais cliniques. La plupart de ces essais reposent sur l’hypothese d’une equivalence de l’effet placebo entre participants recevant un traitement specifique et participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8aba2fb5b91f6d58faed7650070e2e1
https://doi.org/10.1016/s0013-7006(17)30049-0
https://doi.org/10.1016/s0013-7006(17)30049-0
Publikováno v:
L'Encéphale. 42:S33-S42
Proving the efficacy of a psychotropic drug is a medical, scientific and ethical need. Psychotropic drug development is now a highly complex process, which takes several years and which is very expensive. It involves multiple steps of preclinical and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6be36e9dca605611b0c8ce62983792a5
https://doi.org/10.1016/s0013-7006(17)30052-0
https://doi.org/10.1016/s0013-7006(17)30052-0
Publikováno v:
L'Encéphale. 42:S7-S11
Drug development of new compounds implies to define the dosage as well as the conditions of their use (indication, treatment duration, drug interactions, warnings …). This information requires the identification of the time course response. The dec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ab39228531bf305870127cc394c4554
https://doi.org/10.1016/s0013-7006(17)30047-7
https://doi.org/10.1016/s0013-7006(17)30047-7